Evidence map›Paper›PMID 41615515›Full record

ArticleWorld journal of urology2026

Nephrolithiasis in sarcoidosis: epidemiology, risk factors, and clinical implications.

Giovanni Scala Marchini, Sabrina T Reis, Filipe A Correia, Fabio Cesar Miranda Torricelli, Alexandre Danilovic, Fabio Vicentini, Carlos Alfredo Batagello, Ronaldo Adib Kairalla, Alexandre de Melo Kawassaki, Fabio Eiji Arimura and 4 more

Abstract read
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Giovanni Scala MarchiniDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil. marchinnism@gmail.com.
Sabrina T ReisLaboratório de Investigação Médica 55 (LIM55), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, 01246903, SP, Brazil.
Filipe A CorreiaDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil.
Fabio Cesar Miranda TorricelliDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil.
Alexandre DanilovicDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil.
Fabio VicentiniDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil.
Carlos Alfredo BatagelloDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil.
Ronaldo Adib KairallaDivisão de Pneumologia, Faculdade de Medicina, Instituto do Coração, InCor, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brasil.
Alexandre de Melo KawassakiDivisão de Pneumologia, Faculdade de Medicina, Instituto do Coração, InCor, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brasil.
Fabio Eiji ArimuraDivisão de Pneumologia, Faculdade de Medicina, Instituto do Coração, InCor, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brasil.
Patrícia CandidoLaboratório de Investigação Médica 55 (LIM55), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, 01246903, SP, Brazil.
Rodrigo PerrellaDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil.
William Carlos NahasDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil.
Eduardo MazzucchiDivisão de Urologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 7º andar, Cerqueira César, São Paulo, SP, 05403-000, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe the demographic profile and risk factors for kidney stone formation in patients with sarcoidosis. MATERIAL AND

methods158 sarcoidosis patients were analyzed, comparing groups with and without kidney stones evaluating clinical and metabolic factors and medication use. Statistical analysis was carried out using R software (p < 0.05).

resultsThe sample consisted of 138 patients (87.34%), with a majority of females (67.4%) and a median age of 54. Frequent comorbidities included hypertension (38.4%), diabetes (18.1%), and dyslipidemia (6.5%). Nephrolithiasis was reported by 11.9% of patients. Laboratory tests showed hypercalcemia in 9.4% and hypercalciuria in 17.4%. Kidney stones were found in 15.9% of patients, three of whom were bilateral. The comparative analysis revealed a significant association with a previous history of nephrolithiasis (40% vs. 6.6%). There was no statistical correlation with laboratory tests, except for uric acid, which was lower in the group with stones. Hydroxychloroquine was more frequent in the group with stones but without statistical significance. Logistic regression did not identify any significant associations.

conclusionNephrolithiasis occurred in 16% of sarcoidosis patients and was more prevalent in women and adults. Calcium disturbances persist, requiring continuous monitoring. A history of renal lithiasis should be valued in diagnosis and follow-up.

Indexed as

NephrolithiasisSarcoidosisAdultAgedFemaleHumansHypercalcemiaMaleMiddle AgedPrevalenceRetrospective StudiesRisk FactorsHypercalcemiaNephrolithiasisRisk factorsSarcoidosisUrology

Identifiers

PMID41615515
PMCPMC12858569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.